Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, Corbett E, Dara M, Denholm J, de Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go UY, Govindasamy D, D Grant A, Grzemska M, Harris R, Horsburgh CR, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, Lönnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren A, Sañé Schepisi M, Schünemann HJ, Sharma SK, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, van't Hoog A, Varma JK, Vezhnina N, Voniatis C, Vonk Noordegraaf-Schouten M, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M
Eur Respir J. 2015 46 (6): 1563-76

PMID: 26405286 · PMCID: PMC4664608 · DOI:10.1183/13993003.01245-2015

MeSH Terms (30)

Antirheumatic Agents Antitubercular Agents Coinfection Comorbidity Disease Management Drug Users Emigrants and Immigrants Evidence-Based Medicine Health Personnel HIV Infections Homeless Persons Humans Interferon-gamma Release Tests Isoniazid Kidney Failure, Chronic Latent Tuberculosis Mass Screening Practice Guidelines as Topic Prisoners Public Health Radiography, Thoracic Renal Dialysis Rifampin Risk Assessment Silicosis Substance-Related Disorders Transplant Recipients Tuberculin Test Tumor Necrosis Factor-alpha World Health Organization

Connections (1)

This publication is referenced by other Labnodes entities: